Hand Dermatitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2023-01-11
Clinical Trial Update: Apremilast and Moderate to Severe Chronic Hand Dermatitis [Phase 4]
A Phase 4 clinical trial evaluating apremilast for moderate to severe chronic hand dermatitis was withdrawn.